DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation.
Doris Lambracht-Washington, Bao Xi Qu, Min Fu, Larry D. Anderson, Olaf Stüve, Todd N. Eagar, Roger N. Rosenberg
Dive into the research topics of 'DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation.'. Together they form a unique fingerprint.